Healthy Skepticism Library item: 18863
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
John-Baptiste A, Bell C
Industry sponsored bias in cost effectiveness analyses
BMJ 2010 Oct 13; 341:
http://www.bmj.com/content/341/bmj.c5350.extract
Abstract:
Evidence is growing that the involvement of industry in cost effectiveness analyses can affect the findings. A systematic review of published cost-utility analyses found that industry funded studies were more than twice as likely to report a cost-utility ratio below $20 000 (£12 700; $14 850) per quality adjusted life year (QALY) as studies sponsored by non-industry sources.1 The National Institute for Health and Clinical Excellence (NICE) in the United Kingdom found that cost effectiveness analyses submitted by manufacturers produced significantly lower ratios than those derived by assessors at academic centres
